EYE » Topics » If we do not introduce new commercially successful products in a timely manner, our products may become obsolete over time, customers may not buy our products and our revenue and profitability may decline.

These excerpts taken from the EYE 10-K filed Feb 24, 2009.

If we do not introduce new commercially successful products in a timely manner, our products may become obsolete over time, customers may not buy our products and our revenue and profitability may decline.

Demand for our products may change in ways we may not anticipate because of:

 

   

evolving customer needs;

 

   

the introduction of new products and technologies;

 

   

evolving surgical practices; and

 

   

evolving industry standards.

Without the timely introduction of new commercially successful products and enhancements, our products may become obsolete over time, in which case our sales and operating results would suffer. The success of our new product offerings will depend on several factors, including our ability to:

 

   

properly identify and anticipate customer needs;

 

   

commercialize new products in a cost-effective and timely manner;

 

19


Table of Contents
   

manufacture and deliver products in sufficient volumes on time;

 

   

obtain and maintain regulatory approval for such new products;

 

   

differentiate our offerings from competitors’ offerings;

 

   

achieve positive clinical outcomes;

 

   

satisfy the increased demands by health care payors, providers and patients for lower-cost procedures;

 

   

innovate and develop new materials, product designs and surgical techniques; and

 

   

provide adequate medical and/or consumer education relating to new products.

Moreover, innovations generally will require a substantial investment in research and development before we can determine the commercial viability of these innovations and we may not have the financial resources necessary to fund these innovations. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not produce revenue in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.

If we do not introduce new commercially successful products in a timely manner, our products may become
obsolete over time, customers may not buy our products and our revenue and profitability may decline.

Demand for our products may
change in ways we may not anticipate because of:

 







  

evolving customer needs;

 







  

the introduction of new products and technologies;

 







  

evolving surgical practices; and

 







  

evolving industry standards.

SIZE="2">Without the timely introduction of new commercially successful products and enhancements, our products may become obsolete over time, in which case our sales and operating results would suffer. The success of our new product offerings will
depend on several factors, including our ability to:

 







  

properly identify and anticipate customer needs;

 







  

commercialize new products in a cost-effective and timely manner;

 


19







Table of Contents








  

manufacture and deliver products in sufficient volumes on time;

 







  

obtain and maintain regulatory approval for such new products;

 







  

differentiate our offerings from competitors’ offerings;

 







  

achieve positive clinical outcomes;

 







  

satisfy the increased demands by health care payors, providers and patients for lower-cost procedures;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

innovate and develop new materials, product designs and surgical techniques; and

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

provide adequate medical and/or consumer education relating to new products.

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Moreover, innovations generally will require a substantial investment in research and development before we can determine the commercial viability of
these innovations and we may not have the financial resources necessary to fund these innovations. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of
products may not produce revenue in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.


If we do not introduce new commercially successful products in a timely manner, our products may become
obsolete over time, customers may not buy our products and our revenue and profitability may decline.

Demand for our products may
change in ways we may not anticipate because of:

 







  

evolving customer needs;

 







  

the introduction of new products and technologies;

 







  

evolving surgical practices; and

 







  

evolving industry standards.

SIZE="2">Without the timely introduction of new commercially successful products and enhancements, our products may become obsolete over time, in which case our sales and operating results would suffer. The success of our new product offerings will
depend on several factors, including our ability to:

 







  

properly identify and anticipate customer needs;

 







  

commercialize new products in a cost-effective and timely manner;

 


19







Table of Contents








  

manufacture and deliver products in sufficient volumes on time;

 







  

obtain and maintain regulatory approval for such new products;

 







  

differentiate our offerings from competitors’ offerings;

 







  

achieve positive clinical outcomes;

 







  

satisfy the increased demands by health care payors, providers and patients for lower-cost procedures;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

innovate and develop new materials, product designs and surgical techniques; and

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

provide adequate medical and/or consumer education relating to new products.

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Moreover, innovations generally will require a substantial investment in research and development before we can determine the commercial viability of
these innovations and we may not have the financial resources necessary to fund these innovations. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of
products may not produce revenue in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.


These excerpts taken from the EYE 10-K filed Mar 3, 2008.

If we do not introduce new commercially successful products in a timely manner, our products may become obsolete over time, customers may not buy our products and our revenue and profitability may decline.

Demand for our products may change in ways we may not anticipate because of:

 

   

evolving customer needs;

 

   

the introduction of new products and technologies;

 

   

evolving surgical practices; and

 

17


Table of Contents
   

evolving industry standards.

Without the timely introduction of new commercially successful products and enhancements, our products may become obsolete over time, in which case our sales and operating results would suffer. The success of our new product offerings will depend on several factors, including our ability to:

 

   

properly identify and anticipate customer needs;

 

   

commercialize new products in a cost-effective and timely manner;

 

   

manufacture and deliver products in sufficient volumes on time;

 

   

obtain and maintain regulatory approval for such new products;

 

   

differentiate our offerings from competitors’ offerings;

 

   

achieve positive clinical outcomes;

 

   

satisfy the increased demands by health care payors, providers and patients for lower-cost procedures;

 

   

innovate and develop new materials, product designs and surgical techniques; and

 

   

provide adequate medical and/or consumer education relating to new products.

Moreover, innovations generally will require a substantial investment in research and development before we can determine the commercial viability of these innovations and we may not have the financial resources necessary to fund these innovations. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not produce revenue in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.

If we do not introduce new commercially successful products in a timely manner, our products may become
obsolete over time, customers may not buy our products and our revenue and profitability may decline.

Demand for our products may
change in ways we may not anticipate because of:

 







  

evolving customer needs;

 







  

the introduction of new products and technologies;

 







  

evolving surgical practices; and

 


17







Table of Contents








  

evolving industry standards.

SIZE="2">Without the timely introduction of new commercially successful products and enhancements, our products may become obsolete over time, in which case our sales and operating results would suffer. The success of our new product offerings will
depend on several factors, including our ability to:

 







  

properly identify and anticipate customer needs;

 







  

commercialize new products in a cost-effective and timely manner;

 








  

manufacture and deliver products in sufficient volumes on time;

 







  

obtain and maintain regulatory approval for such new products;

 







  

differentiate our offerings from competitors’ offerings;

 







  

achieve positive clinical outcomes;

 







  

satisfy the increased demands by health care payors, providers and patients for lower-cost procedures;

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

innovate and develop new materials, product designs and surgical techniques; and

STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"> 







  

provide adequate medical and/or consumer education relating to new products.

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Moreover, innovations generally will require a substantial investment in research and development before we can determine the commercial viability of
these innovations and we may not have the financial resources necessary to fund these innovations. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of
products may not produce revenue in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.


This excerpt taken from the EYE 10-K filed Mar 1, 2007.

If we do not introduce new commercially successful products in a timely manner, our products may become obsolete over time, customers may not buy our products and our revenue and profitability may decline.

Demand for our products may change in ways we may not anticipate because of:

·                  evolving customer needs;

·                  the introduction of new products and technologies;

·                  evolving surgical practices; and

·                  evolving industry standards.

Without the timely introduction of new commercially successful products and enhancements, our products may become obsolete over time, in which case our sales and operating results would suffer. The success of our new product offerings will depend on several factors, including our ability to:

·                  properly identify and anticipate customer needs;

·                  commercialize new products in a cost-effective and timely manner;

·                  manufacture and deliver products in sufficient volumes on time;

·                  obtain regulatory approval for such new products;

·                  differentiate our offerings from competitors’ offerings;

·                  achieve positive clinical outcomes;

·                  satisfy the increased demands by health care payors, providers and patients for lower-cost procedures;

15




·                  innovate and develop new materials, product designs and surgical techniques; and

·                  provide adequate medical and/or consumer education relating to new products and attract key surgeons to advocate these new products.

Moreover, innovations generally will require a substantial investment in research and development before we can determine the commercial viability of these innovations and we may not have the financial resources necessary to fund these innovations. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not produce revenue in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.

This excerpt taken from the EYE 10-K filed Mar 14, 2006.

If we do not introduce new commercially successful products in a timely manner, our products may become obsolete over time, customers may not buy our products and our revenue and profitability may decline.

 

Demand for our products may change in ways we may not anticipate because of:

 

                  evolving customer needs;

 

                  the introduction of new products and technologies;

 

                  evolving surgical practices; and

 

                  evolving industry standards.

 

Without the timely introduction of new commercially successful products and enhancements, our products may become obsolete over time, in which case our sales and operating results would suffer. The success of our new product offerings will depend on several factors, including our ability to:

 

                  properly identify and anticipate customer needs;

 

                  commercialize new products in a cost-effective and timely manner;

 

                  manufacture and deliver products in sufficient volumes on time;

 

                  obtain regulatory approval for such new products;

 

                  differentiate our offerings from competitors’ offerings;

 

                  achieve positive clinical outcomes;

 

                  satisfy the increased demands by health care payors, providers and patients for lower-cost procedures;

 

                  innovate and develop new materials, product designs and surgical techniques; and

 

                  provide adequate medical and/or consumer education relating to new products and attract key surgeons to advocate these new products.

 

Moreover, innovations generally will require a substantial investment in research and development before we can determine the commercial viability of these innovations and we may not have the financial resources necessary to fund these innovations. In addition, even if we are able to successfully develop enhancements or new generations of our products, these enhancements or new generations of products may not produce revenue in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki